BioDelivery Sciences International Inc. (BDSI)

2.15
0.03 1.10
NASDAQ : Health Technology
Prev Close 2.17
Open 2.20
Day Low/High 2.10 / 2.20
52 Wk Low/High 1.60 / 3.60
Volume 51.08K
Avg Volume 426.30K
Exchange NASDAQ
Shares Outstanding 58.45M
Market Cap 131.51M
EPS 0.10
P/E Ratio 22.50
Div & Yield N.A. (N.A)

Latest News

BioDelivery Sciences Announces Ohio Workers Compensation Adding BELBUCA And BUNAVAIL To Formulary

BioDelivery Sciences Announces Ohio Workers Compensation Adding BELBUCA And BUNAVAIL To Formulary

Action taken as part of response to opioid crisis in State

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Breaches Of Fiduciary Duty By BioDelivery Sciences International, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Breaches Of Fiduciary Duty By BioDelivery Sciences International, Inc.

Levi & Korsinsky announces it has commenced an investigation of BioDelivery Sciences International, Inc.

4 Small-Caps on My Earnings Watch List

4 Small-Caps on My Earnings Watch List

We are coming my favorite part of earnings season -- when these small-caps report.

3 Biotech Stocks on Readers' Minds

3 Biotech Stocks on Readers' Minds

We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.

Trump's FDA: A Friendlier Biotech Sheriff

Trump's FDA: A Friendlier Biotech Sheriff

There still will be winners and losers, but the new administration's FDA is a net plus for the industry.

2 Recovering Biotech Names With Room to Run

2 Recovering Biotech Names With Room to Run

There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.

4 Undervalued Biotech Stocks

4 Undervalued Biotech Stocks

Two are turnaround stories, and two are oversold.

2 Oversold Biopharmas With Big 2017 Upsides

2 Oversold Biopharmas With Big 2017 Upsides

Flexion Therapeutics and BioDelivery Sciences are well below what they once fetched.

3 Small Biotech Value Plays

3 Small Biotech Value Plays

These stocks will be great stories in the second half of 2017, and are significantly undervalued.

Welcome to the Small-Cap Biotech Mailbag!

Welcome to the Small-Cap Biotech Mailbag!

We answer recent reader questions about three of the biotech stocks we regularly cover.

My Top 2017 Pick: Progenics Pharmaceuticals

My Top 2017 Pick: Progenics Pharmaceuticals

This biopharma company's Relistor drug should send revenues sharply higher this year.

Top 2017 Pick: Progenics Pharmaceuticals

Top 2017 Pick: Progenics Pharmaceuticals

This biopharma company's Relistor drug should send revenues sharply higher next year.

Endo International Is Top 'Dog of the S&P 500'

Endo International Is Top 'Dog of the S&P 500'

There are more dogs on the S&P 500 than on the Dow. Here's one example.

Some 'January Effect' Stock Picks

Some 'January Effect' Stock Picks

Small-caps could also benefit from abating tax-loss selling.

Small Biotechs on My Shopping List

Small Biotechs on My Shopping List

These small-caps are woefully undervalued after getting shellacked in October.

3 Stocks for Growth in 2017

3 Stocks for Growth in 2017

BioDelivery Sciences, Progenics Pharma and Sequential Brands are off-the-radar small-caps poised for a big year in 2017.

BioDelivery Sciences (BDSI) Stock Jumps on Ratings Upgrade

BioDelivery Sciences (BDSI) Stock Jumps on Ratings Upgrade

BioDelivery Sciences' (BDSI) stock rating was boosted at Janney Capital on Friday.

TheStreet Quant Rating: D+ (Sell)